Does food change how this heart pill works? new study investigates
NCT ID NCT07043634
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed Phase 3 study in 24 healthy adults examines whether taking a fixed-dose combination of extended-release torsemide and spironolactone with or without food changes how the body absorbs the drugs. Participants receive a single dose under both conditions, and researchers measure drug levels in blood and urine. The goal is to guide dosing instructions for this heart failure medication.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- torsemide and spironolactone combination pill
- What this could lead to
- If it works, this could help doctors know whether to take this pill with or without food for best absorption.
- What could go wrong
- This is a small, early-stage study in healthy volunteers, not patients. Results may not apply to people with heart or kidney conditions who would actually use the drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIOAVAILABILITY HEATHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sarfez Pharmaceuticals
Vienna, Virginia, 22182, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Seaweed crackers: a superfood delivery system?
- New combo pill for fluid retention passes first Body-Processing test in healthy volunteers
- New glutathione formula shows promise in small study
- Which CoQ10 supplement works best? new study aims to find out
- New trazodone formula tested for similarity to current version